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Although the microbiota protects the host from infection, pathogens are still able to colonize and cause dis-
ease. In this issue of Cell Host & Microbe, Maier et al. (2013) provide mechanistic insight into the initial stages
of Salmonella growth in the gut, showing that microbiota-derived hydrogen provides an energy boost to
Salmonella.In healthy individuals, the intestinal micro-
biota comprises a very diverse commu-
nity. Largely composed of obligate anaer-
obes of the phyla Bacteroidetes and
Firmicutes, these microbes contribute to
the development of the immune system
and confer colonization resistance to
infection with enteric pathogens (Lawley
andWalker, 2013). A variety of commensal
bacteria are now known to modulate
mucosal immunity via several mecha-
nisms, including the stimulation of regula-
tory T cell and T helper 17 cell develop-
ment (Lawley and Walker, 2013), as well
as by triggering the release of cytokines,
like interleukin 22, that are responsible
for inducing antimicrobial responses
(Zelante et al., 2013). And yet, despite
the protective effect of both the micro-
biota and the host’s mucosal immunity,
enteric pathogens can still colonize the
host and cause disease.
The biggest hurdles enteric pathogens
must clear upon entering the intestine, an
environment already densely populated
by the microbiota and lacking in nutrients,
are overcoming mucosal immunity and
finding the means with which to replicate.
It thus follows that the most successful
enteric pathogens have evolved strate-
gies to outcompete the microbiota as
well as to thrive in an environment as hos-
tile as the inflamed gut. One of the best ex-
amples of such a pathogen is Salmonella
enterica serovar Typhimurium, a major
cause of inflammatory diarrhea.
Previous studies have shown thatS. Ty-
phimurium exploits intestinal inflamma-
tion to colonize the gut and to compete
with the microbiota via several mecha-
nisms (Thiennimitr et al., 2011a). For
example, intestinal inflammation sup-
presses the colonization of Bacteroidetesand Firmicutes, and enhances S. Typhi-
murium colonization by providing electron
acceptors like nitrate and tetrathionate
that allow Salmonella to generate more
ATP in the anaerobic environment of
the intestine (Lopez et al., 2012; Winter
et al., 2010). Additionally, Salmonella
colonization of the inflamed intestine is
enhanced by chemotaxis toward high-en-
ergy nutrients like mucins (Stecher et al.,
2008), by utilization of host-derived etha-
nolamine as a carbon source (Thiennimitr
et al., 2011b), and by acquisition of metal
nutrients like iron and zinc (Liu et al., 2012;
Raffatellu et al., 2009), all of which
contribute to the enhanced growth of
Salmonella over competing microbes
that cannot utilize or effectively scavenge
these nutrients.
While it is now accepted that intesti-
nal inflammation is crucial to support
Salmonella replication and to suppress
the growth of microbial competitors, the
mechanisms by which Salmonella initially
grows in the intestinal niche, already
dominated by the microbiota, are not
well understood. In this issue of Cell
Host & Microbe, an elegant study by Ma-
ier et al. provides insight into how Salmo-
nella exploits themicrobiota at the earliest
stages of infection (Maier et al., 2013).
To search for the mechanism by which
Salmonella initially achieves replication
in the gut, the authors employed mice
colonized with a low complex microbiota
(LCM); in contrast to conventional spe-
cific pathogen-free (SPF) mice, LCM
mice are more permissive for the growth
of Salmonella in the gut and eventually
develop intestinal inflammation without
streptomycin pretreatment. A transposon
mutant screen in LCM mice identified
genes involved in anaerobic metabolism,Cell Host & Microbe 14, Dincluding a NiFe hydrogenase (hyb),
which catalyzes the oxidation of hydrogen
through a nickel (Ni)- and iron (Fe)-depen-
dent mechanism, and the fumarate
reductase complex (frdA), which converts
fumarate to succinate. In an anaerobic
environment, the NiFe hydrogenase
Hyb consumes molecular hydrogen,
subsequently transferring the electrons
down to the respective reductases for
acceptors like fumarate and nitrate. The
outcome of this process is an energy
boost for Salmonella, followed by the
rapid growth of this pathogen in the
intestine.
With a series of meticulous experi-
ments, the authors showed that a strain
of S. Typhimurium carrying a deletion of
the structural Hyb hydrogenase genes
was highly defective during the first day
of Salmonella infection, before the onset
of the intestinal inflammatory response.
Moreover, intestinal inflammation did not
exacerbate the defect of the hyb mutant,
indicating that hydrogen consumption
via the Hyb hydrogenase provides an
advantage to Salmonella primarily during
the initial phases of intestinal colonization.
As indicated by the transposon mutant
screen, an S. Typhimurium strain carrying
a deletion of the fumarate reductase sub-
unit FrdA also showed a colonization
defect, suggesting that fumarate is a likely
terminal electron acceptor for molecular
hydrogen utilization before the onset of
inflammation. At later stages of infection,
other electron acceptors like nitrate and
tetrathionate, whose availability depends
on the host inflammatory response,
further enhance the replication of Salmo-
nella in the inflamed intestine and enable
its competition with the microbiota (Lopez
et al., 2012; Winter et al., 2010).ecember 11, 2013 ª2013 Elsevier Inc. 603
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PreviewsVirtually all of the available hydrogen in
the intestine originates from microbial
fermentation of carbohydrates. In this
study, analysis of all publicly available
metagenomes confirmed that hydrogen
production represents a universal feature
of the cecal microbiota in the intestinal
tract of animals and humans, including
LCM mice. In contrast, in both germ-free
mice and mice treated with antibiotics,
hydrogen was absent or low, and conse-
quently a functional Hyb hydrogenase
did not provide a colonization advantage
to Salmonella. Moreover, as some intesti-
nal microbes consume hydrogen, con-
verting it to methane or hydrogen sulfide,
the amount of intestinal hydrogen is
directly influenced by the microbiota’s
balance between ‘‘hydrogen producers’’
and ‘‘hydrogen consumers.’’ Consistent
with this idea, precolonization of LCM
mice with hydrogen consumers reduced
the availability of hydrogen and thusly
hampered Hyb-dependent colonization
by Salmonella.
Altogether, this study sheds light on the
complex interaction between Salmonella
and the microbiota. On the one hand, the
microbiota is known to provide coloniza-
tion resistance to Salmonella infection, as
antibiotic treatment increases the suscep-
tibility to Salmonella both in experimental604 Cell Host & Microbe 14, December 11, 20and in clinical settings. On the other
hand, the microbiota is exploited by
Salmonella, which utilizes the microbiota-
derived hydrogen to replicate to higher
levels. As the availability of nutrients can
affect the composition of the gut micro-
biome, and thus potentially hydrogen
production, this work also suggests that
infection riskmaydepend inpart ondietary
habits and in part on the microbial bal-
ance between hydrogen producers and
hydrogen consumers. Specifically, coloni-
zation with hydrogen consumersmay pro-
tect against the initial ecosystem invasion
by Salmonella and likely by other patho-
gens that may utilize Hyb hydrogenases
for their initial replication. In contrast, at
later stages of infection, hydrogen con-
sumers that release hydrogen sulfide
may enhance the growth of Salmonella
by cooperating with the host to form tetra-
thionate (Winter et al., 2010). Neverthe-
less, manipulation and modulation of the
microbiota and its metabolic functions
may provide potential targets to reduce
the colonization and expansion of Salmo-
nella and other enteric pathogens.REFERENCES
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Autophagy is important for innate defense against intracellular bacteria, such as Group A Streptococcus
(GAS). In this issue of Cell Host & Microbe, Barnett et al. (2013) demonstrate that the globally disseminated
serotype M1T1 clone of GAS can evade autophagy via streptococcal cysteine protease SpeB-mediated
degradation of ubiquitin-LC3 adaptor proteins.Group A Streptococcus (GAS or Strepto-
coccus pyogenes) is a strictly human
pathogen that normally colonizes the
throat and skin without causing disease.
Members of this species are classified
into over 100 serotypes by the immuno-genic differences in their surface M pro-
tein and polymorphisms in their emm
genes (Facklam et al., 2002). GAS is
responsible for a wide variety of infec-
tions, including localized and systemic in-
fections that can cause acute or chronicillness (Carapetis et al., 2005). In most
cases, GAS causes pharyngitis (sore
throat), tonsillitis, or skin infections such
as impetigo. At times, GAS can cause
severe and even life-threatening infec-
tions, such as necrotizing fasciitis and
